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Available online 23 February 2018Tubal ectopic pregnancies are a leading cause of globalmaternalmorbidity andmortality. Previous infectionwith
Chlamydia trachomatis is a major risk factor for tubal embryo implantation but the biological mechanism behind
this association is unclear. Successful intra-uterine embryo implantation is associated with increased expression
of endometrial “receptivity” integrins (cell adhesion molecules). We examined integrin expression in Fallopian
tubes of women with previous C. trachomatis infection, in mice experimentally infected with C. trachomatis, in
immortalised human oviductal epithelial cells (OE-E6/E7) and in an in vitromodel of human embryo attachment
(trophoblast spheroid-OE-E6/7 cell co-culture). Previous exposure with C. trachomatis increased Fallopian tube/
oviduct integrin-subunit beta-1 (ITGB1) in women and mice compared to controls. C. trachomatis increased OE-
E6/E7 cell ITGB1 expression and promoted trophoblast attachment to OE-E6/E7 cells which was negated by anti-
ITGB1-antibody.We demonstrate that infection with C. trachomatis increases tubal ITGB1 expression, predispos-
ing to tubal embryo attachment and ectopic pregnancy.ductive Health, Univ
le France Crescent, Ed
.
. This is an open access© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).Keywords:
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An ectopic pregnancy is a pregnancy that implants outside themain
cavity of theuterus,most commonly in the Fallopian tube. It occurs in 1–
2% of all pregnancies worldwide and remains the most common cause
of maternal morbidity and mortality in the ﬁrst trimester of pregnancy
(Jurkovic and Wilkinson 2011). Chlamydia trachomatis (C. trachomatis)
is the most prevalent curable bacterial sexually transmitted disease
worldwide, with an estimated incidence of N100 million cases per
year (WHO, 2012). Epidemiological studies indicate that previous pelvic
C. trachomatis infection is a major risk factor for ectopic pregnancy
(Bakken et al. 2007). However, the mechanism by which C. trachomatis
infection leads to tubal implantation is not understood and does not ap-
pear to be a direct consequence of tissue destruction by the organismersity of
inburgh
article under(J. L. V. Shaw et al. 2011b). We propose that C. trachomatis infection of
tubal epithelial cells may alter their phenotype predisposing to ectopic
embryo attachment and implantation later in a woman's reproductive
life.
In the human uterus, the putative “window of receptivity” to the
embryo (that is required for successful intra-uterine implantation to
occur), in the mid-luteal phase of the menstrual cycle, is accompanied
by increased endometrial expression of integrin heterodimers, com-
posed of the integrin subunits (ITG) alpha 1 (ITGA1), beta 1 (ITGB1),
alpha 4 (ITGA4), alpha v (ITGAV) and beta 3 (ITGB3) (Lessey 1998).
Integrins are a family of widely-expressed cell surface receptors that
mediate cell–cell and cell–extracellular matrix adhesion and, as a result,
regulate many aspects of cell behavior. Twenty-four different integrin
heterodimers are currently recognized in humans, each comprising a
pair of non-covalently associated ITGA and ITGB subunits (Barczyk et
al. 2010). In addition to providing a physical transmembrane link be-
tween the extracellular environment and the cytoskeleton, they are ca-
pable of transducing bi-directional signals across the cell membrane
(Hynes 2002). Unlike the uterus, all ﬁve of the ITG markers of receptiv-
ity (ITGB1, ITGB3, ITGA1, ITGA4 and ITGAV) are constitutively expressedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(Brown et al. 2012). We therefore hypothesised that previous infection
with C. trachomatismay predispose to tubal implantation by increasing
tubal integrin expression.
To address our hypothesis, we examined integrin transcript and pro-
tein expression in the Fallopian tube of women with serological evi-
dence of previous infection with C. trachomatis. We then assessed
integrin expression in response to C. trachomatis infection in the ovi-
ducts of mice and in human immortalised oviductal epithelial cells
(OE-E6/E7). Finally, due to the lack of a good in vivo animal model of
tubal ectopic pregnancy (in animals the abdominal cavity is the most
frequent extra-uterine implanation site) (Brown and Horne 2011), we
used an in vitro human trophoblast spheroid (embryo surrogate) –
Fallopian tube epithelial cell co-culture model to investigate the effect
of C. trachomatis exposure and functional blockage of integrin on em-
bryo attachment.
2. Materials and Methods
2.1. Patient Samples
Ethical approval for this study was obtained from the Lothian Re-
search Ethics Committee (LREC 04/S1103/20, 05/S1103/14, 07/S1103/
29), with informed, written consent obtained from all study partici-
pants. Serum samples and full thickness cross-sections of human
Fallopian tube ampulla (total n = 26) were collected from women un-
dergoing hysterectomy for benign gynaecological conditions. This
group of women had a regular 21–35 day menstrual cycle, were non-
smokers, not using contraception and had no obvious evidence of FT pa-
thology on microscopic examination (as assessed by an expert histopa-
thologist). Fallopian tubes samples were saved either into RNAlater
(Applied Biosystems, Warrington, UK) for RNA extraction or into neu-
tral-buffered formalin (NBF) for parafﬁn embedding. Previous C.
trachomatis infectionwas determined by an indirect enzyme-linked im-
munosorbent assay to serum Pgp3 antibody (Wills et al. 2009) with a
cut-off value for absorbance at 450 nm of ≥0.473 giving ≥96% speciﬁcity
(with an observed decline in seropositivity occurring following the last
episode of chlamydial infection). Of the 26women, 8 had serological ev-
idence of previous C. trachomatis infection and 18 had no serological ev-
idence of previous C. trachomatis infection.
2.2. Animal Studies
The animal studies were approved by the Moredun Research Insti-
tute Ethics Committee andwere conducted adhering to the institution's
guidelines for animal husbandry under licence from the UK Home Of-
ﬁce. Eight week old female C57/BL6 mice were infected with C.
trachomatis (Fig. 2a) following a modiﬁed protocol published by
Darville et al. (1997) and described inmore detail in Supplementary In-
formation (Animal Studies).
2.3. Isolation of DNA From Vaginal Swabs and Quantitative Real-time PCR
DNA was extracted from vaginal swabs using a DNeasy® Blood and
Tissue Kit (Qiagen, Cat No. 69504) according to the manufacturer's in-
structions. Evidence of infection with C. trachomatis was determined
by TaqMan real-time PCR using the C. trachomatis speciﬁc primers and
probes (see Supplementary Table 1) (Darville et al. 1997). DNA extrac-
tion and qRT-PCRmethods are described in detail in Supplementary In-
formation (Isolation of DNA from vaginal swabs and quantitative real-
time PCR).
2.4. Quantitative Reverse Transcription PCR for Integrin mRNA Expression
TaqMan real-time PCR (qRT-PCR) was performed to quantify mRNA
expression levels of human and mouse integrins using speciﬁc primers(see Supplementary Table 1) following the protocol described in Sup-
plementary Information (Quantitative reverse transcription PCR for
integrin mRNA expression).
2.5. Immunohistochemistry
Immunohistochemistry for ITGB1 in human Fallopian tube samples
and Itgb1 in mouse oviducts was carried out on NBF ﬁxed parafﬁn
wax embedded (FPE) sections following our previously described pro-
tocol (Brown et al. 2012) and detailed in Supplementary Information
(Immunohistochemistry). The primary antibodies used to detect
ITGB1 (both for human as well as human samples) were rabbit-anti-
ITGB1 (Santa Cruz sc-8978, diluted 1:100) or isotype matched control
(Rabbit IgG Dako X0903, diluted 1:100).
2.6. Histoscore Calculation
Sections of immunohistochemical staining for ITGB1were evaluated
using semiquantitative histoscore analysis following previously de-
scribed method which considers both the intensity and the percentage
of cells stained in each of four intensity categories (McCarty et al.
1985). Intensities were classiﬁed as 0 (no staining), 1 (weak staining),
2 (strong staining) and 3 (very strong staining). For each stained sec-
tion, a histoscore was obtained by application of the following algo-
rithm: histoscore =∑(i + 1) × Pi, where i and Pi represent intensity
and percentage of cells that stain at each intensity, respectively, and cor-
responding histoscores were then calculated.
2.7. Quantitative Dual-ﬂuorescent Western Blot
Quantitative dual-ﬂuorescent western blot was performed to quan-
tify the ITGB1 and ITGB3 proteins in human Fallopian tube lysates fol-
lowing our previously established protocol (Brown et al. 2012) and
detailed in Supplememntary Information (Quantitative dual-ﬂuores-
cent western blot). Primary antibodies used to detect ITGB1 were rab-
bit-anti-ITGB1 (Santa Cruz sc-8978, dilution 0.5 μg/ml) and for ITGB3
were rabbit anti-ITGB3 (Santa Cruz sc-14,009, dilution 0.5 μg/ml).
2.8. Oviductal Epithelial OE-E6/E7 Cell Culture and C. trachomatis Infection
Immortalised human oviductal epithelial OE-E6/E7 cells (sourced
from KF Lee, Hong Kong) were maintained in DMEM/F12 containing
10% fetal bovine serum at 37 °C, 5% CO2. OE-E6/E7 cells were seeded
at 5 × 105 cells per well of a 12-well dish (BD Biosciences) and cultured
for 24 h. Cells were thenwashedwith PBS and incubated overnightwith
serum-free DMEM/F12. The OE-E6/E7 cells (triplicate wells) were ex-
posed to live C. trachomatis (serovar E) at MOI values of 0.1 and 1.0 in
serum-free DMEM/F12. Control cells were cultured in medium alone.
After 24 h, medium was removed and the cells were treated with
Qiagen RLT buffer and frozen at−80 °C before RNA extraction.
2.9. Trophoblastic Spheroid-oviduct Epithelial-cell co-culture Model
A previously established co-culture model using human
immortalised Swan71 trophoblast cells (kind gift from V. Abrahams,
Yale School of Medicine, CT) (Gipson et al. 2008) and human
immortalised OE-E6/E7 oviductal epithelial cells, designed to simulate
trophoblast attachment, was modiﬁed (Kodithuwakku et al. 2012).
Human immortalised were cultured in Dulbecco's Modiﬁed Essential
Medium (DMEM, Invitrogen) supplemented with 10% fetal bovine
serum (FBS, Invitrogen), 2 mM L-glutamine, penicillin/streptomycin
(Invitrogen) and non-essential amino acids (Sigma). Swan71 cells are
derived from ﬁrst trimester trophoblasts and are well characterised
(Straszewski-Chavez et al. 2009). Both cell lines were tested for myco-
plasma prior to use. Swan71 cells were seeded at 2000 cells per well
in a 96 well non-adherent round bottom tissue culture plate to
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plates of OE-E6/E7 cells were washed and maintained in serum-free
conditions. For C. trachomatis infection experiments, OE-E6/E7 cells
were exposed to C. trachomatis, as described in the previous section.
Triplicate wells were treated for 1 h with 0.1 or 0.01 μg/ml mouse
anti-ITGB1 (Clone P5D2: R&D Systems) or equivalent concentration of
isotype-matched control IgG1 (Sigma) prior to careful transfer of sixteen
Swan71 spheroids onto the OE-E6/E7 monolayers and a further 6 h in-
cubation. Non-adherent spheroids were removed by gentle washing
with PBS before the cells were ﬁxed for 10 min in NBF, washed and
stored in 70% ethanol. Swan71 spheroids adherence was quantiﬁed
using light microscopy. Percentage adherence was derived by division
of the number of spheroids attached by total number of spheroids.
2.10. Statistical Analysis
Statistical analysis was performed using GraphPad PRISM, version
6.1. To allow for small sample sizes, non-parametric testingwas applied
to analysis of human and animal studies. As endometrial integrins are
upregulated at the window of receptivity, data were interrogated to de-
tect a signiﬁcant increase in integrin transcript and protein levels using
the one-tailed Mann Whitney test. For in vitro work, normality of data
was tested using Shapiro-Wilk test and Kruskal-Wallis or one-way
ANOVA accordingly applied, with correction for multiple comparisons
by Dunn's or Dunnett's tests, respectively. Differences were considered
signiﬁcant if P b 0.05.
3. Results
3.1. ITGB1 Expression Is Increased in the Fallopian Tube of Non-pregnant
Women with Evidence of Previous C. trachomatis Infection
We ﬁrst investigated mRNA expression levels of ITGB1, ITGB3,
ITGA1, ITGA4 and ITGAV in Fallopian tube fromwomenwith serological
evidence of previous C. trachomatis infection (non-pregnant and non-
smokers). We found that expression of ITGB1 mRNA was higher (P b
0.05) in Fallopian tube from women with evidence of previous C.
trachomatis infection (n = 8) compared to those without (n = 18)
(Fig. 1a). ITGB1 protein expression in Fallopian tube from women
with previous C. trachomatis infection (n = 7) correlated with ITGB1
mRNA levels (R= 0.442, P= 0.026), but changes in protein expression
alone, compared to a control group (n= 13), did not reach signiﬁcance
(Fig. 1b). Immunohistochemistry demonstrated abundant Fallopian
tube epithelium ITGB1 expression in women with previous C.
trachomatis infection and mild stromal staining (n = 8; Fig. 1d, g). In
contrast, in women without previous C. trachomatis infection (n =
18), only sporadic cell staining was observed (Fig. 1c, f). Semiquantita-
tive histoscore analysis revealed a signiﬁcant increase (P b 0.0001) in
ITGB1 expression in Fallopian tube epithelial cells inwomenwith previ-
ous C. trachomatis infection as compared to womenwithout previous C.
trachomatis infection (Fig. 1h). Although ITGB3 mRNA expression was
increased (P b 0.05) in women with previous C. trachomatis infection
(Supplementary Fig. 1a), ITGB3 protein levels did not show any signiﬁ-
cant changes (Supplementary Fig. 1b) nor did they correlatewithmRNA
levels. Tubal expression of ITGA1, ITGA4 and ITGAVwere not affected by
previous C. trachomatis infection (Supplementary Fig. 1c, 1d and 1e).
3.2. Oviductal Itgb1 Expression Is Increased by C. Trachomatis in a Mouse
Model of Previous Infection
To investigate causality between C. trachomatis infection and in-
creased ITGB1, we developed an in vivo mouse model of previous C.
trachomatis infection (Fig. 2a). Female C57BL/6 mice were infected
intra-vaginallywith C. trachomatis and conﬁrmed to have cleared the in-
fection by day 30 post-infection by qRT-PCR detection of C. trachomatis
genomic DNA (n = 6) (Fig. 2b). Mice infected with C. trachomatisdisplayed increased expression of oviductal Itgb1 mRNA compared to
sham-infected controls (n = 6) on day 60 post-infection (P b 0.05)
(Fig. 2c). Immunohistochemistry to Itgb1 revealed strongly positive ep-
ithelial cells in the oviducts isolated frommice exposed to C. trachomatis
(Fig. 2e, h), with limited staining in the sham-infected mice (Fig. 2d, g).
Semiquantitative histoscore analysis revealed a signiﬁcant increase (P b
0.05) in ITGB1 expression in oviductal epithelial cells inmice exposed to
C. trachomatis as compared to controls (Fig. 1h). Exposure to C.
trachomatis did not cause any signiﬁcant changes in Itgb3 mRNA ex-
pression levels in murine oviducts (Supplementary Fig. 2).
3.3. Exposure to C. trachomatis Increases ITGB1 mRNA Expression in Hu-
man Immortalised Oviductal Epithelial Cells
ITGB1mRNA expression in human immortalised oviductal epithelial
OE-E6/E7 cells was signiﬁcantly increased following 24 h of exposure to
1.0multiplicity of infection (MOI) C. trachomatis compared to control (P
b 0.05) (Fig. 3a). Exposure to 0.1 MOI C. trachomatis did not have any
signiﬁcant effect on ITGB1 mRNA expression.
3.4. C. Trachomatis Exposure Increases Trophoblast Spheroid Attachment to
Oviductal Epithelial Cells by Upregulating ITGB1
There are no good animal models of tubal ectopic pregnancy, so to
simulate embryo attachment we used an in vitro trophoblastic spheroid
(embryo surrogate) - Fallopian tube epithelial-cell co-culture model.
We demonstrated that 24 h exposure of oviductal epithelial OE-E6/E7
cells to 1.0MOI C. trachomatis signiﬁcantly increased trophoblast spher-
oid attachment (P b 0.0001) (Fig. 3b). However, treatment of the C.
trachomatis exposed OE-E6/E7 cells with 0.1 μg/ml ITGB1 neutralising
antibody (dose selected following optimisation, data not shown) for
1 h prior to trophoblast spheroid introduction, signiﬁcantly reduced
the numbers of spheroids that attached to the OE-E6/E7 monolayer
compared with C. trachomatis exposed OE-E6/E7 cells (P b 0.0001)
and isotype control (IgG) exposed OE-E6/E7 cells (P b 0.0001).
4. Discussion
It is accepted that C. trachomatis infection in women predisposes to
tubal ectopic pregnancy; a relationship that continues for many years
after the infection has resolved and that cannot be explained bymacro-
scopic tissue damage as a result of inﬂammation (Barczyk et al. 2010, J.
L. Shaw et al. 2011a). In this study, we providemechanistic evidence for
changes in cell adhesion molecule expression that may explain this ep-
idemiological association. Using ex vivo, animal in vivo and in vitro func-
tional models, we demonstrate that previous exposure to C. trachomatis
infection increases oviductal epithelial cell expression of the adhesion
molecule ITGB1, predisposing to ectopic embryo attachment.
Fallopian tube from women with serological evidence of previous
exposure to C. trachomatis expressed higher levels of ITGB1 mRNA,
with abundant immunolocalisation of protein to the Fallopian tube ep-
ithelium. This upregulation of mRNA and localisation of protein was
replicated in our in vivomodel of previous C. trachomatis infection and
in immortalised oviductal epithelial cells. Epithelium-speciﬁc expres-
sion is important in the context of ectopic pregnancy, as it is to these
cells the embryowill initially attach in vivo. In utero, integrins are upreg-
ulated at the luminal surface of the endometrium during thewindow of
implantation (Lessey et al. 1992) and interact with corresponding li-
gands on the blastocyst trophectoderm to enable attachment
(Burrows et al. 1993). Through the use of our in vitromodel of Fallopian
tube - embryo attachment, we have for the ﬁrst time been able to show
the effect of over-expression of ITGB1 on embryo attachment. This
model allows investigation of causality in ectopic pregnancy which is
not possible by examining human biopsies of tubal implantation sites
where molecular changes may be an artefact of implantation and/or
presence of an embryo as opposed to a predisposition for ectopic
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Fig. 1. The effect of previous C. trachomatis infection on Fallopian tube ITGB1 expression in women. (a) Box-and-whisker plots of relative levels of ITGB1 mRNA expression (measured by
qRT-PCR) in Fallopian tube biopsies from non-pregnant, non-smoking womenwho tested negative (Ct–ve; n= 18) or positive (Ct+ve; n= 8) for previous C. trachomatis infection. The
boxes represent mean values±1 standard deviation and the whiskers denote the full range of the data. (*P b 0.05, one-tailed MannWhitney test). (b) Box-and-whisker plots of levels of
ITGB1 protein (measured bywestern blot analysis) from the samewomen (where therewas sufﬁcient sample). The boxes representmean values±1 standard deviation and thewhiskers
denote the full range of the data. (P= 0.2, one-tailedMannWhitney test). (c) and (d) Representative images of immunohistochemical localization of ITGB1 in Fallopian tube tissue from
Ct–ve and Ct+ vewomen, respectively. Bar = 50 μm. (f) and (g) Higher magniﬁcation of c and d respectively. Bar = 20 μm. (e) Negative IgG control. Bar = 50 μm. (h) Box and whicker
plots of ITGB1 histoscore in Fallopian tube biopsies from women with and without previous C. trachomatis infection. The boxes represent mean values ±1 standard deviation and the
whiskers denote the full range of the data. (****P b 0.0001, one tailed Mann Whitney test).
162 S.F. Ahmad et al. / EBioMedicine 29 (2018) 159–165implantation. In addition, in the absence of a good animalmodel of tubal
ectopic pregnancy, we have utilised an alternative in vivomodel, where
mice are exposed to C. trachomatis and allowed to clear the infection, to
study the effects of C. trachomatis on the oviduct. The natural history of
untreated (or treated) pelvic chlamydial infection in women cannot be
observed for ethical and logistical reasons, and randomized controlled
trials do not provide this information because the time from the start
of the infection is unknown. We propose that further study using this
model could signiﬁcantly contribute to improvements in clinical man-
agement of this prevalent infection (Akande et al. 2010; Howie et al.
2011).
We acknowledge that our results demonstrate that Fallopian tube
ITGB1 increases in response to C. trachomatis infection but do not ex-
plain how, the effect endures following elimination of the infection in
the face of oviductal epithelial cell turnover and regeneration. This effect
is also seen in ocular trachomawhere scarring progresses in the absenceof detectable C. trachomatis infection, raising uncertainty about the pri-
mary drivers of late-stage trachoma (Burton et al. 2015). Persistence
(where the organism adopts a dormant state in the epithelial cells) oc-
curs in a minority of C. trachomatis infections and may contribute to
some cases of ectopic pregnancy (Bjartling et al. 2007). In addition,
Kessler et al. have recently demonstrated the existence of Fallopian
tube stem cells, present along the Fallopian tube epithelial surface,
with the ability to differentiate into an organoid containing both ciliated
and secretory epithelial cell types in culture (Kessler et al. 2015). It
would be interesting to discover if bacterial alterations to the genome
of these cells by C. trachomatis, resulting in persistent ITGB1 upregula-
tion,may account for the long-term increased risk of ectopic pregnancy.
We also acknowledge that further work is required to elaborate the
full mechanistic pathway of Fallopian tube ITGB1 regulation by C.
trachomatis. However, we propose that the utilization of host cell
ITGB1 that we have observed in oviductal epithelial cells as a result of
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163S.F. Ahmad et al. / EBioMedicine 29 (2018) 159–165C. trachomatis infection, may be due to a shared bacterial virulence
mechanism. C. trachomatis is an obligate intracellular, Gram-negative
bacterium. C. trachomatis switches between an extracellular, metaboli-
cally inactive, infectious form, the elementary body (EB), and an intra-
cellular replicative form, the reticulate body. Stallman and Hegemann
have recently shown that C. trachomatis EBs produce the adhesin and
invasin molecule Ctad1 (Stallmann and Hegemann 2016). This speciﬁ-
cally binds ITGB1 on epithelial cells and induces clustering of ITGB1 at
the epithelial cell membrane to allow EB entry into the host cell. Anoth-
er Gram-negative bacterium, Shigella, upregulates expression of ITGB1
in epithelial cells ITGB1, in this case to stabilize intestinal epithelial
cell adhesion to the extracellular matrix and prevent cellular detach-
ment (Kim et al. 2009). Shigellae utilize the type III secretion system(T3SS) to introduce the effector protein OspE into the cell, and OspE in-
teracts with the host-cells integrin-linked kinase ILK, which in turn
upregulates ITGB1 (Kim et al. 2009). C. trachomatis also makes use of
the type III secretion system; a “membrane-embedded nanomachine”
that delivers virulence proteins into a host cell via a hollow needle
which then hijack host cell machinery. Chemical inhibition of T3SS dra-
matically reduces C. trachomatis virulence (Muschiol et al. 2006). It is
therefore possible that C. trachomatis shares a similar bacterial virulence
mechanism and that small molecule inhibitors to such bacterial viru-
lence factorsmight provide an effective preventative therapy for ectopic
pregnancy in women previously infected with C. trachomatis.
In summary, we have shown that C. trachomatis upregulates oviduc-
tal epithelial ITGB1 expression which predisposes to ectopic embryo
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Fig. 3. Effect of C. trachomatis infection on immortalised human Fallopian tube epithelial OE-E6/E7 cells and an in vitromodel of human embryo attachment. (a) Box and whisker plots of
relative levels of ITGB1mRNA expression (measured by qRT-PCR) in Fallopian tube epithelial OE-E6/E7 cells following exposure to C. trachomatis for 24 h (MOI=multiplicity of infection).
The boxes represent mean values ±1 standard deviation and the whiskers denote the full range of the data. Data are the mean of six biological replicates. (*P b 0.05, Kruskal-Wallis test
with Dunn's multiple comparisons post-test). (b) Trophoblast spheroid-oviductal epithelial cell attachment following 24 h exposure to C. trachomatis±1 h pre-treatment with 0.1 μg/ml
anti-ITGB1 antibody. The box-and-whisker plots illustrate percentage adherence (number of spheroids attached/total number of spheroids) of SW-71 trophoblast spheroids to oviductal
epithelial OE-E6/E7 cells. The boxes representmean values±1 standard deviation and thewhiskers denote the full range of the data. Data are themean of four biological replicates. (**** P
b 0.0001, one-way Anova and Dunnett's multiple comparisons post-test).
164 S.F. Ahmad et al. / EBioMedicine 29 (2018) 159–165attachment. This provides an explanation for the epidemiological asso-
ciation between C. trachomatis and reproductive life-time risk of ectopic
pregnancy. The pathways and mechanisms leading to long-term over-
expression of ITGB1 require further study but may be a consequence
of bacterial effector proteins hijacking cellular pathways to promote vir-
ulence leading to more complex disease outcomes.
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